{
    "2018-01-07": [
        [
            {
                "time": "",
                "original_text": "华东医药:独家DPP-4抑制剂成药潜力明显,公司正从仿制向创新转型升级",
                "features": {
                    "keywords": [
                        "华东医药",
                        "DPP-4抑制剂",
                        "成药潜力",
                        "仿制",
                        "创新",
                        "转型"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}